APAC Interstitial Cystitis Market - Industry Trends and Forecast to 2029

APAC Interstitial Cystitis Market - Industry Trends and Forecast to 2029

The Asia-Pacific interstitial cystitis market is projected to register a substantial CAGR of 12.1% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation

By Severity (Mild to Moderate and Moderate to Severe), Treatment Type (Medications, Bladder Instillations, Botulinum Toxin A, Nerve Stimulation and Surgery), Route of Administration (Oral, Parenteral, Intravesical, Topical, and Others), Mode of Purchase (Over The Counter and Prescription), Patient Type (Pediatric and Adults), End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the Asia-Pacific interstitial cystitis market are:
• Rise in prevalence of interstitial cystitis
• Increasing investment in R&D of novel drugs

Market Players

Some of the major players operating in the Asia-Pacific interstitial cystitis market are:
• Alvogen
• Sandoz AG
• Sun Pharmaceutical Industries Ltd.
• Avet Pharmaceuticals Inc.
• Viatris Inc.
• Pfizer, Inc.
• Strides Pharma Science Limited
• GlaxoSmithKline plc.
• Prestige Consumer Healthcare Inc.
• Amneal Pharmaceuticals LLC
• Zydus Pharmaceuticals, Inc.
• Apotex Inc.
• Aurobindo Pharma USA
• Dr. Reddy’s Laboratories, Inc.
• Johnson& Johnson Services, Inc.
• Teva Pharmaceuticals, Inc.
• Bayer AG
• Reckitt Benckiser Group PLCCompanies

• Alvogen
• Sandoz AG
• Sun Pharmaceutical Industries Ltd.
• Avet Pharmaceuticals Inc.
• Viatris Inc.
• Pfizer, Inc.
• Strides Pharma Science Limited
• GlaxoSmithKline plc.
• Prestige Consumer Healthcare Inc.
• Amneal Pharmaceuticals LLC
• Zydus Pharmaceuticals, Inc.
• Apotex Inc.
• Aurobindo Pharma USA
• Dr. Reddy’s Laboratories, Inc.
• Johnson& Johnson Services, Inc.
• Teva Pharmaceuticals, Inc.
• Bayer AG
• Reckitt Benckiser Group PLC

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.